1.020USD+0.99%Mkt Cap: 18.02M USDP/E: —Last update: 2026-05-26
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap18.02M USD
Enterprise Value23.26M USD
Revenue (TTM)52.58M USD
Gross Profit19.23M USD
Net Income (TTM)-4.44M USD
Revenue/Share3.078 USD
Last Price1.020 USD
Fiscal Year EndJan 2026
MR QuarterApr 2026
Employees93
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)50.50
PEG0.94
EV/EBITDA-9.40
EV/Revenue0.44
P/S0.33
P/B-16.29
EPS (TTM)-0.19
EPS (Forward)0.02
52W Range
0.870019% of range1.650
52W High1.650 USD
52W Low0.8700 USD
Profitability
Gross Margin36.50%
Oper. Margin-2.75%
EBITDA Margin-4.71%
Profit Margin-8.42%
ROE-90.15%
ROA-15.22%
Growth
Revenue Growth-0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.12M USD
CapEx (TTM)143.00K USD
FCF Margin1.89%
FCF Yield5.51%
Net Debt-319.00K USD
Net Debt/EBITDA0.13
Balance Sheet
Debt/Equity0.92
Current Ratio1.92
Quick Ratio1.01
Book Value/Sh-0.0620 USD
Cash/Share0.2640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)2.750 USD
Target Range2.750 USD – 2.750 USD
# Analysts1
Ownership
Shares Out.17.41M
Float11.41M
Insiders28.92%
Institutions18.04%
Short Interest
Short Ratio0.1d
Short % Float0.51%
Short % Out.0.32%
Shares Short56.46K
Short (prev mo.)32.48K
Technical
SMA 501.097 (-7.0%)
SMA 2001.177 (-13.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)64.29K
Avg Vol (10d)59.93K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—